MPDL3280A-treatment-IST-UMCG
MPDL3280A Treatment in Patients With Locally Advanced or Metastatic Solid Tumors After or During Investigational Imaging
Sponsor: University Medical Center Groningen
This PHASE2 trial investigates Locally Advanced or Metastatic Solid Tumors and is currently ongoing. University Medical Center Groningen leads this study, which shows 15 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
Feb 2024 — Jun 2024 [monthly]
Active Not Recruiting PHASE2
-
Apr 2023 — Feb 2024 [monthly]
Active Not Recruiting PHASE2
▶ Show 10 earlier versions
-
Mar 2023 — Apr 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Feb 2023 — Mar 2023 [monthly]
Recruiting PHASE2
-
Apr 2022 — Feb 2023 [monthly]
Recruiting PHASE2
-
Jan 2021 — Apr 2022 [monthly]
Recruiting PHASE2
-
Nov 2019 — Jan 2021 [monthly]
Recruiting PHASE2
-
Mar 2019 — Nov 2019 [monthly]
Recruiting PHASE2
-
Nov 2018 — Mar 2019 [monthly]
Recruiting PHASE2
-
Jul 2018 — Nov 2018 [monthly]
Recruiting PHASE2
Status: Active Not Recruiting → Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Medical Center Groningen
For direct contact, visit the study record on ClinicalTrials.gov .